PDSS1 and hepatocellular carcinoma: Our study provides multiple lines of evidence to confirm that PDSS1 is a therapeutic target and prognostic predictor of HCC and promotes the progression of HCC by regulating the STAT3 signaling pathway and immune cell infiltration.